Data Factory
Reading the graph
Reading the graph
Private Equity
New York, NY
Principles for Responsible Investing
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | ADV type | Form D sold | GAV | LPs |
|---|---|---|---|---|---|---|
| Madryn Health Partners II Overage, LP | 2024 | Unknown | Private Equity Fund | n/a | $0 | 0 |
| Madryn Health Partners II (cayman Master), LP | 2022 | Early deployment | Private Equity Fund | n/a | $595M | 0 |
| Madryn Select Opportunities, LP | 2022 | Unknown | Private Equity Fund | n/a | $109M | 0 |
| Madryn Health Partners II, LP | 2022 | Early deployment | Private Equity Fund | n/a | $39.6M | 0 |
| Madryn Health Partners, LP | n/a | Harvest | Private Equity Fund | n/a | $153M | 0 |
| Madryn Health Partners (cayman Master) LP | n/a | Harvest | Private Equity Fund | n/a | $252M | 0 |
| Company | State | Role | Control | Invested | Exited | Status |
|---|---|---|---|---|---|---|
| NeoGraft Solutions | n/a | Add on | control | Feb 2, 2018 | n/a | active |
| NeoGraft Solutions | n/a | Add on | control | Feb 2, 2018 | n/a | active |
| Aquestive | n/a | unknown | unknown | n/a | n/a | unknown |
| Bigfoot Biomedical | n/a | unknown | unknown | n/a | n/a | unknown |
| BioQ Pharma | n/a | unknown | unknown | n/a | n/a | unknown |
| Calibrate | n/a | unknown | unknown | n/a | n/a | unknown |
| Dialyze Direct | n/a | unknown | unknown | n/a | n/a | unknown |
| Establishment Labs | n/a | unknown | unknown | n/a | n/a | unknown |
| Fuze Health | n/a | unknown | unknown | n/a | n/a | unknown |
| Intuity Medical | n/a | unknown | unknown | n/a | n/a | unknown |
| Leiters | n/a | unknown | unknown | n/a | n/a | unknown |
| Mainstay Medical | n/a | unknown | unknown | n/a | n/a | unknown |
| Monteris Medical | n/a | unknown | unknown | n/a | n/a | unknown |
| Neuronetics | n/a | unknown | unknown | n/a | n/a | unknown |
| Omada Health | n/a | unknown | unknown | n/a | n/a | unknown |
| SomaLogic | n/a | unknown | unknown | n/a | n/a | unknown |
| Veracyte | n/a | unknown | unknown | n/a | n/a | unknown |
| Veran Medical | n/a | unknown | unknown | n/a | n/a | unknown |
| Willow Innovations | n/a | unknown | unknown | n/a | n/a | unknown |
| Venus Concept | n/a | platform | unknown | n/a | n/a | active |
| Venus Concept | n/a | unknown | unknown | n/a | n/a | unknown |
Also named here, with no published line of their own (reach them through the firm): Pierre Nmn Somers (Majority Owner).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan